1 | TM-5 | 19 Jan 2010 |
10 | Order | 09 Jan 2023 |
2 | TM-16 | 19 Sep 2015 |
3 | Opponents Affidavit Rule | 22 May 2018 |
4 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 06 Oct 2022 |
5 | Annexure -1 under rule 46 | 13 Oct 2022 |
5 | Evidence Affidavit Under Rule 46 (TOP) | 13 Oct 2022 |
6 | Annexure -1 under rule 46 | 13 Oct 2022 |
6 | Evidence Affidavit Under Rule 46 (TOP) | 13 Oct 2022 |
7 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 14 Nov 2022 |
8 | Annexure -1 under rule 46 | 28 Dec 2022 |
8 | Evidence Affidavit Under Rule 46 (TOP) | 28 Dec 2022 |
9 | Annexure -1 under rule 46 | 28 Dec 2022 |
9 | Evidence Affidavit Under Rule 46 (TOP) | 28 Dec 2022 |
1 | Opposition Counter Statement | 4852386 | 20 Jun 2017 | |
2 | Opposition Counter Statement | 4853224 | 20 Jun 2017 | |
3 | Opposition Counter Statement | 4853228 | 20 Jun 2017 | |
4 | Hearing Notice | 14275866 | 5751949 | 31 Oct 2022 |
5 | Hearing Notice | 14354494 | 5767889 | 17 Nov 2022 |
6 | Hearing Notice | 14354666 | 5767878 | 17 Nov 2022 |
7 | Hearing Notice | 14470919 | 5795829 | 12 Dec 2022 |
The application for Gabanext was made on 12 May 2006.
The trademark applicant for Gabanext is EMCURE PHARMACEUTICALS.
Gabanext is applied in class(es) 5.
Application for Gabanext is on Opposed stage.
Application Id allotted to Gabanext is 1450697.
Trademark agent or attorney for the application is Aditya & Associates.
Gabanext filed with the Intellectual property office as a WORD.